[BLOOD COAGULATION CHANGES AND THEIR RELATION TO THE EFFECT OF DRUGS IN HYPERTENSION].
D000925:Anticoagulants; D008725:Bis-Trimethylammonium Compounds; D001777:Blood Coagulation; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D002118:Calcium; D004071:Digitalis Glycosides; D004358:Drug Therapy; D005165:Factor V; D005340:Fibrinogen; D005342:Fibrinolysis; D005730:Ganglionic Blockers; D006493:Heparin / Q000627:therapeutic use*; D006584:Hexamethonium Compounds; D006801:Humans; D006973:Hypertension; D009125:Muscle Relaxants, Central; D009525:Niacin; D010208:Papaverine; D011517:Prothrombin Time; D012110:Reserpine; D013328:Strophanthins; D013917:Thrombin; D013925:Thromboplastin
D000925:Anticoagulants; D008725:Bis-Trimethylammonium Compounds; D001779:Blood Coagulation Factors; D004071:Digitalis Glycosides; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D009125:Muscle Relaxants, Central; D013328:Strophanthins; C100246:azamethonium compounds; D009525:Niacin; D012110:Reserpine; D005165:Factor V; D005340:Fibrinogen; D006493:Heparin; D013925:Thromboplastin; D010208:Papaverine; D013917:Thrombin; D002118:Calcium
ANTICOAGULANTS; AZAMETHONIUM COMPOUNDS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CALCIUM; DIGITALIS GLYCOSIDES; DRUG THERAPY; FACTOR V; FIBRINOGEN; FIBRINOLYSIS; GANGLIONIC BLOCKADERS; HEPARIN, THERAPEUTIC; HEXAMETHONIUM COMPOUNDS; HYPERTENSION; MUSCLE RELAXANTS; NICOTINIC ACID; PAPAVERINE; PROTHROMBIN TIME; RESERPINE; STROPHANTHIN; THROMBIN; THROMBOPLASTIN
IZMENENIIA SVERTYVAEMOSTI KROVI V SVIAZI S LEKARSTVENNYMI VOZDE ISTVIIAMI PRI GIPERTONICHESKO I BOLEZNI.